Search fresh public links, source activity, and post angles for Precision Oncology.
Fresh curated links around precision oncology are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Discover how biomarker strategies are transforming oncology trials and accelerating precision medicine breakthroughs.
When cancer treatment fails, physicians face one of the hardest questions in medicine: what should come next? Having recently cared for a young patient whose cancer had returned de...
What You Should Know Precision medicine has transitioned from “one-off” testing to organized institutional programs at more than three-quarters of surveyed U.S. health systems, acc...
RNA sequencing combined with multiomic analysis uncovers new therapeutic targets in advanced cancers, enabling identification of antibody drug conjugate options when DNA testing al...
Why biomarker-driven oncology trials require new thinking across patient recruitment, assay development and regulatory strategy.
New data shows potential for ctDNA to guide treatment decisions for patients with triple-negative breast cancer
Despite remarkable progress in medical science, the prognosis for most patients diagnosed with advanced-stage cancers remains bleak. The challenge lies not only in the complexity o...
As MRD shifts from prognostic marker to intervention trigger, sponsors must rethink trial design, endpoints and decision-making.
In a groundbreaking advancement presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026), researchers have unveiled a promising approach to tail...
Path-IO accurately stratified immunotherapy outcomes for patients with metastatic non-small cell lung cancer (NSCLC). The model is validated across international real-world cohorts...
Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Ra...
Two patients walk into an oncology clinic with what looks, on paper, like the same melanoma. Same stage, same tumor size, comparable bloodwork. One lives for a decade. The other is...
In a groundbreaking study unveiled at the ESMO Breast Cancer 2026 congress in Berlin, researchers have illuminated a compelling opportunity to address a pivotal gap in cancer genet...
RNA sequencing of blood samples may help predict immune response to chemoimmunotherapy and support more personalized treatment strategies for high-risk...
As radiopharmaceuticals continue to evolve, the convergence of scientific innovation, operational practicality, and clinical expertise is opening new possibilities in oncology. Th...
RNA sequencing improves sarcoma diagnosis by detecting gene fusions and refining classifications, enabling more accurate treatment decisions and better patient...
RNA sequencing and genomic profiling adoption is rising across cancers, yet disparities in access and delayed testing continue to limit timely precision oncology treatment decision...
Fragmented data limits even the most advanced oncology AI. Curated knowledge changes that.
Over the past decade, the treatment landscape for gastro-oesophageal adenocarcinoma (GEA) has undergone a remarkable transformation, driven by evolving epidemiological trends, grou...
Today’s organoid companies underscore proof points in the ability to model complex human biology with high fidelity. At the same time, the government’s evolving regulatory stance i...
In a groundbreaking advancement at the intersection of artificial intelligence and oncology, researchers have unveiled a pioneering method that harnesses machine learning to accele...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.